ATNX
|Athenex Inc
NASDAQ
USD
|%
Current Price
Change
(%)
P/E Ratio
Dividend Yield
Market Cap
2.33M
Volume
Open
Previous Close
52-Week High
52-Week Low
About Athenex Inc
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through Oncology Innovation Platform and Commercial Platform segments. The company's Orascovery product candidates include Oral paclitaxel and encequidar for the treatment of metastatic breast cancer. It also offers Src Kinase product candidates comprising Tirbanibulin ointments for actinic keratosis, skin cancers, and psoriasis. In addition, ...
Sector:Healthcare
Industry:Biotechnology & Medical Research
CEO:Dr. Yiu-Nam Lau F.R.C.P., M.B.B.S., M.D., Ph.D.
Employees:269
Headquarters:Buffalo, USA
Website:www.athenex.com
Dividend History
Dividend Payments
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Similar Companies
Explore Stocks by Sector
technology
finance
healthcare
Frequently Asked Questions